Jane Street Group, LLC Pro Qr Therapeutics N.V. Transaction History

Jane Street Group, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$1.99 - $3.66 $73,870 - $135,862	37,121 Added 198.01%	55,868 $118,000
Q4 2022 Feb 14, 2023	BUY	$0.8 - $3.7 $577 - $2,671	722 Added 4.01%	18,747 $69,000
Q3 2022 Nov 14, 2022	SELL	$0.74 - $0.89 $95,854 - $115,284	-129,533 Reduced 87.78%	18,025 $13,000
Q2 2022 Aug 16, 2022	BUY	$0.56 - $1.0 $69,926 - $124,869	124,869 Added 550.35%	147,558 $115,000
Q1 2022 May 17, 2022	BUY	$0.9 - $8.39 $4,963 - $46,270	5,515 Added 32.11%	22,689 $21,000
Q4 2021 Feb 15, 2022	BUY	$6.58 - $8.44 $37,453 - $48,040	5,692 Added 49.57%	17,174 $138,000
Q3 2021 Nov 16, 2021	BUY	$5.16 - $8.47 $59,247 - $97,252	11,482 New	11,482 $96,000
Q2 2021 Aug 16, 2021	SELL	$5.75 - $7.59 $190,859 - $251,934	-33,193 Closed	0 $0
Q1 2021 May 18, 2021	BUY	$4.14 - $9.22 $80,158 - $178,517	19,362 Added 139.99%	33,193 $219,000
Q4 2020 Feb 17, 2021	BUY	$3.58 - $4.85 $6,512 - $8,822	1,819 Added 15.14%	13,831 $58,000
Q3 2020 Nov 17, 2020	BUY	$4.79 - $6.3 $57,537 - $75,675	12,012 New	12,012 $58,000
Q3 2019 Nov 14, 2019	SELL	$5.76 - $9.44 $58,371 - $95,664	-10,134 Closed	0 $0
Q2 2019 Aug 15, 2019	BUY	$9.1 - $15.55 $92,219 - $157,583	10,134 New	10,134 $92,000

17.4M

37.7K

21.3K

Ticker PRQR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,362,096
Market Cap $258M
Description
ProQR Therapeutics N.V., a biopharmaceutical company, engages in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. It primarily develops sepofarsen that is in phase II/III clinical trial illuminate trial for treating leber congenital amaurosis 10 disease; and ultevursen, which is in phase II/III clin...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.